(Q51103821)

English

A 1-year prospective cost-effectiveness analysis of roflumilast for the treatment of patients with severe chronic obstructive pulmonary disease.

scientific article published in January 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17640111%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

A 1-year prospective cost-effectiveness analysis of roflumilast for the treatment of patients with severe chronic obstructive pulmonary disease (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17640111%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

chronic obstructive pulmonary disease

1 reference

based on heuristic

inferred from title

Maureen Rutten-van Molken

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17640111%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

author name string

Floortje E van Nooten

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17640111%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Marion Lindemann

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17640111%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Manfred Caeser

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17640111%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Peter M A Calverley

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17640111%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

publication date

1 January 2007

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17640111%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

PharmacoEconomics

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17640111%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

25

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17640111%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17640111%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

695-711

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17640111%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

https://scigraph.springernature.com/pub.10.2165/00019053-200725080-00007

0 references

Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200725080-00007

21 January 2018

The burden of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200725080-00007

21 January 2018

The impact of aging and smoking on the future burden of chronic obstructive pulmonary disease: a model analysis in the Netherlands

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200725080-00007

21 January 2018

A dynamic population model of disease progression in COPD.

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200725080-00007

21 January 2018

An economic overview of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200725080-00007

21 January 2018

Resource use and risk factors in high-cost exacerbations of COPD.

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200725080-00007

21 January 2018

Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease.

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200725080-00007

21 January 2018

Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200725080-00007

21 January 2018

Roflumilast--an oral anti-inflammatory treatment for chronic obstructive pulmonary disease: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200725080-00007

21 January 2018

Dynamic hyperinflation: is it worth measuring?

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200725080-00007

21 January 2018

Standardization of Spirometry, 1994 Update. American Thoracic Society

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200725080-00007

21 January 2018

The friction cost method for measuring indirect costs of disease.

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200725080-00007

21 January 2018

Interpreting thresholds for a clinically significant change in health status in asthma and COPD.

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200725080-00007

21 January 2018

Multiple imputation in health-care databases: an overview and some applications

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200725080-00007

21 January 2018

Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation.

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200725080-00007

21 January 2018

Costs, effects and C/E-ratios alongside a clinical trial.

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200725080-00007

21 January 2018

Cost-effectiveness acceptability curves--facts, fallacies and frequently asked questions

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200725080-00007

21 January 2018

Definition, interpretation and calculation of cost-effectiveness acceptability curves.

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200725080-00007

21 January 2018

Assessment of progression of COPD: report of a workshop held in Leuven, 11-12 March 2004

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200725080-00007

21 January 2018

The analysis of incomplete cost data due to dropout

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200725080-00007

21 January 2018

Estimating medical costs from incomplete follow-up data

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200725080-00007

21 January 2018

One-year cost-effectiveness of tiotropium versus ipratropium to treat chronic obstructive pulmonary disease.

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200725080-00007

21 January 2018

Estimating the cost-effectiveness of fluticasone propionate for treating chronic obstructive pulmonary disease in the presence of missing data

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200725080-00007

21 January 2018

Cost effectiveness of budesonide/formoterol in a single inhaler for COPD compared with each monocomponent used alone

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200725080-00007

21 January 2018

Design, analysis and presentation of multinational economic studies: the need for guidance

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200725080-00007

21 January 2018

Generalisability in economic evaluation studies in healthcare: a review and case studies.

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200725080-00007

21 January 2018

Estimating country-specific cost-effectiveness from multinational clinical trials

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200725080-00007

21 January 2018

Using multilevel models for assessing the variability of multinational resource use and cost data.

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200725080-00007

21 January 2018

Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200725080-00007

21 January 2018

Systemic effects of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200725080-00007

21 January 2018

Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/17640111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire

1 reference

https://pubmed.ncbi.nlm.nih.gov/17640111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-effectiveness of inhaled corticosteroids for chronic obstructive pulmonary disease according to disease severity

1 reference

https://pubmed.ncbi.nlm.nih.gov/17640111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessing generalisability by location in trial-based cost-effectiveness analysis: the use of multilevel models

1 reference

https://pubmed.ncbi.nlm.nih.gov/17640111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51103821&oldid=1399377971"